Está en modo consejo Apagar
Para moverse rápido entre los bloques

Organización: Takeda Pharmaceutical
LEI 549300ZLMVP4X0OGR454

Nombre de la empresa
Takeda Pharmaceutical Company Limited
Nombre del país
Japón
País de registro
Japón
Industria
Fabricación de medicina y biotecnología
Deuda de bonos
19.046 mln USD

explore la más completa base de datos

800 000

bonos globalmente

Más de 400

fuentes de precios

80 000

acciones

9 000

ETF

siga su portfolio de la manera más eficiente
búsqueda de bonos
Watchlist
Excel ADD-IN

Últimos datos al

Cotizaciones

Consulta enviada
Acceso denegado
Cotizaciones facilitadas por los proveedores de la información son indicativas

Perfil

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The companys drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in the U.S., Europe, and Asia. From these bases, the company markets its original products.The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including clinical diagnostics, photographic chemicals, and inorganic chemicals. In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.Takeda Pharmaceutical Company Limited was founded in 1781.

Premios

Documentos

Acciones

Últimas emisiones

Deuda en bonos según divisa

Códigos

  • LEI
    549300ZLMVP4X0OGR454
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001395064

Calificaciones de riesgo y de ESG

Macroeconomía

Hay que registrarse para recibir el acceso.